Cardiovascular risk factor control in British adults with diabetes mellitus: Retrospective cohort study

Sophie É Collins1,2, Brendan Cord Lethebe3, Tyler Williamson3

  • 1Division of General Internal Medicine Faculty of Medicine & Dentistry University of Alberta Edmonton AB Canada.

Insights

Cardiovascular risk factor control in British adults with diabetes is suboptimal one year post-diagnosis. Quality improvement strategies are needed to manage all risk factors, not just blood sugar levels.

Area of Science:

  • Cardiology
  • Endocrinology
  • Public Health

Background:

  • Diabetes mellitus is a major risk factor for cardiovascular disease.
  • Effective management of cardiovascular risk factors is crucial for preventing complications in diabetic patients.
  • Primary care plays a vital role in managing diabetes and its associated risks.

Purpose of the Study:

  • To assess the control of key cardiovascular risk factors in adults with diabetes mellitus within the first year of diagnosis.
  • To identify the proportion of patients achieving targets for HbA1c, systolic blood pressure (SBP), LDL cholesterol, and smoking status.
  • To evaluate the need for enhanced quality improvement strategies in diabetes care.

Main Methods:

  • Utilized electronic medical records from the UK Health Improvement Network Database (2003-2015).
  • Analyzed data from 292,170 British adults diagnosed with diabetes mellitus.
  • Examined cardiovascular risk factor control at a median of 354 days post-diagnosis, considering glycemic control (HbA1c), blood pressure, LDL cholesterol, and smoking status.

Main Results:

  • Overall control of cardiovascular risk factors was suboptimal, with only 14.7% meeting all targets (HbA1c <7%, SBP <140 mmHg, LDL ≤1.8 mmol/L or on statin, non-smoker).
  • Specific control rates included: HbA1c <7% (52.0%), SBP <140 mmHg (53.1%), LDL ≤1.8 mmol/L or on statin (90.4%), and non-smokers (86.0%).
  • Despite 71.4% receiving antihypertensive agents, only 53.1% achieved SBP <140 mmHg, highlighting a gap in blood pressure management.

Conclusions:

  • There is a significant need for improved quality of care targeting multiple cardiovascular risk factors in individuals with diabetes.
  • Current management strategies may not be sufficiently effective in achieving comprehensive risk factor control.
  • Future interventions should focus on a holistic approach to managing atherosclerotic risk factors beyond glycemic control alone.

Related Concept Videos

Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
4.2K
Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
1.9K
Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
785
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
4.7K
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
530
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
781